Sanofi Acquires Vicebio for $1.15B, Bolstering Vaccine Pipeline
What You Should Know:
– Sanofi has entered into an agreement to acquire Vicebio Ltd (“Vicebio”), a privately held biotechnology company headquartered in London, UK. The acquisition expands Sanofi’s capabilities in vaccine design and development…
Continue Reading
